183 related articles for article (PubMed ID: 18707958)
1. Positron emission tomography-CT imaging in guiding musculoskeletal biopsy.
O'Sullivan PJ; Rohren EM; Madewell JE
Radiol Clin North Am; 2008 May; 46(3):475-86, v. PubMed ID: 18707958
[TBL] [Abstract][Full Text] [Related]
2. The clinical efficacy of (18)F-FDG-PET/CT in benign and malignant musculoskeletal tumors.
Shin DS; Shon OJ; Han DS; Choi JH; Chun KA; Cho IH
Ann Nucl Med; 2008 Aug; 22(7):603-9. PubMed ID: 18756363
[TBL] [Abstract][Full Text] [Related]
3. Accuracy of computed tomography guided core needle biopsy of musculoskeletal tumours.
Altuntas AO; Slavin J; Smith PJ; Schlict SM; Powell GJ; Ngan S; Toner G; Choong PF
ANZ J Surg; 2005 Apr; 75(4):187-91. PubMed ID: 15839962
[TBL] [Abstract][Full Text] [Related]
4. [F-18]fluorodeoxyglucose positron emission tomography and positron emission tomography: computed tomography in recurrent and metastatic cholangiocarcinoma.
Jadvar H; Henderson RW; Conti PS
J Comput Assist Tomogr; 2007; 31(2):223-8. PubMed ID: 17414758
[TBL] [Abstract][Full Text] [Related]
5. Positron emission tomography imaging of musculoskeletal tumors in the shoulder girdle.
Suzuki H; Watanabe H; Shinozaki T; Yanagawa T; Suzuki R; Takagishi K
J Shoulder Elbow Surg; 2004; 13(6):635-47. PubMed ID: 15570232
[TBL] [Abstract][Full Text] [Related]
6. Fluorodeoxyglucose-PET/Computed Tomography-Guided Biopsy.
Cerci JJ; Tabacchi E; Bogoni M
PET Clin; 2016 Jan; 11(1):57-64. PubMed ID: 26590444
[TBL] [Abstract][Full Text] [Related]
7. Strategies for Biopsy of Musculoskeletal Tumors.
Daley NA; Reed WJ; Peterson JJ
Semin Roentgenol; 2017 Oct; 52(4):282-290. PubMed ID: 28965547
[No Abstract] [Full Text] [Related]
8. Accuracy of CT-guided biopsies in 359 patients with musculoskeletal lesions.
Hau A; Kim I; Kattapuram S; Hornicek FJ; Rosenberg AE; Gebhardt MC; Mankin HJ
Skeletal Radiol; 2002 Jun; 31(6):349-53. PubMed ID: 12073119
[TBL] [Abstract][Full Text] [Related]
9. 18F-FDG-PET of musculoskeletal tumors: a correlation with the expression of glucose transporter 1 and hexokinase II.
Hamada K; Tomita Y; Qiu Y; Zhang B; Ueda T; Myoui A; Higuchi I; Yoshikawa H; Aozasa K; Hatazawa J
Ann Nucl Med; 2008 Oct; 22(8):699-705. PubMed ID: 18982473
[TBL] [Abstract][Full Text] [Related]
10. Fusion of metabolic function and morphology: sequential [18F]fluorodeoxyglucose positron-emission tomography/computed tomography studies yield new insights into the natural history of bone metastases in breast cancer.
Du Y; Cullum I; Illidge TM; Ell PJ
J Clin Oncol; 2007 Aug; 25(23):3440-7. PubMed ID: 17592153
[TBL] [Abstract][Full Text] [Related]
11. Is combined 18F-fluorodeoxyglucose-positron emission tomography/computed tomography superior to positron emission tomography or computed tomography alone for diagnosis, staging and restaging of pancreatic lesions?
Casneuf V; Delrue L; Kelles A; Van Damme N; Van Huysse J; Berrevoet F; De Vos M; Duyck P; Peeters M
Acta Gastroenterol Belg; 2007; 70(4):331-8. PubMed ID: 18330088
[TBL] [Abstract][Full Text] [Related]
12. FDG PET/CT of primary bone tumors.
Costelloe CM; Chuang HH; Madewell JE
AJR Am J Roentgenol; 2014 Jun; 202(6):W521-31. PubMed ID: 24848845
[TBL] [Abstract][Full Text] [Related]
13. Increased (18)F-fluorodeoxyglucose uptake in benign, nonphysiologic lesions found on whole-body positron emission tomography/computed tomography (PET/CT): accumulated data from four years of experience with PET/CT.
Metser U; Even-Sapir E
Semin Nucl Med; 2007 May; 37(3):206-22. PubMed ID: 17418153
[TBL] [Abstract][Full Text] [Related]
14. Assessment of combination of contrast-enhanced magnetic resonance imaging and positron emission tomography/computed tomography for evaluation of ovarian masses.
Tsuboyama T; Tatsumi M; Onishi H; Nakamoto A; Kim T; Hori M; Sakane M; Hori Y; Morii E; Hatazawa J; Tomiyama N
Invest Radiol; 2014 Aug; 49(8):524-31. PubMed ID: 24637584
[TBL] [Abstract][Full Text] [Related]
15. Comparison of cell proliferation, protein, and glucose metabolism in musculoskeletal tumors in a PET study.
Tian M; Zhang H; Endo K
J Biomed Biotechnol; 2011; 2011():807929. PubMed ID: 21738405
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic Accuracy of PET/CT-Guided Percutaneous Biopsies for Malignant Peripheral Nerve Sheath Tumors in Neurofibromatosis Type 1 Patients.
Brahmi M; Thiesse P; Ranchere D; Mognetti T; Pinson S; Renard C; Decouvelaere AV; Blay JY; Combemale P
PLoS One; 2015; 10(10):e0138386. PubMed ID: 26445379
[TBL] [Abstract][Full Text] [Related]
17. Accurate diagnosis of musculoskeletal lesions by core needle biopsy.
Mitsuyoshi G; Naito N; Kawai A; Kunisada T; Yoshida A; Yanai H; Dendo S; Yoshino T; Kanazawa S; Ozaki T
J Surg Oncol; 2006 Jul; 94(1):21-7. PubMed ID: 16788939
[TBL] [Abstract][Full Text] [Related]
18. Dual-tracer PET/CT imaging in evaluation of metastatic hepatocellular carcinoma.
Ho CL; Chen S; Yeung DW; Cheng TK
J Nucl Med; 2007 Jun; 48(6):902-9. PubMed ID: 17504862
[TBL] [Abstract][Full Text] [Related]
19. [Positron emission tomography-computed tomography in tumors of the locomotor apparatus].
Gámez Cenzano C; Sabaté Llobera A; Narváez García JA; Rodríguez Bel L; García del Muro FJ
Radiologia; 2012 Sep; 54 Suppl 1():3-13. PubMed ID: 22959330
[TBL] [Abstract][Full Text] [Related]
20. Accuracy of CT-guided needle biopsy of musculoskeletal neoplasms.
Dupuy DE; Rosenberg AE; Punyaratabandhu T; Tan MH; Mankin HJ
AJR Am J Roentgenol; 1998 Sep; 171(3):759-62. PubMed ID: 9725312
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
